查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1570685

AAV 包裝服務市場：按應用程式、最終用戶、向量類型、製造方法、組件分類 - 2025-2030 年全球預測

AAV Packaging Service Market by Application, End User (Academic Institutions, Biopharmaceutical Companies, Contract Research Organizations ), Vector Type, Production Method, Component - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年 AAV 包裝服務市值為 17.2 億美元，預計到 2024 年將達到 18.4 億美元，複合年成長率為 5.39%，預計到 2030 年將達到 24.9 億美元。

AAV（腺結合病毒）包裝服務市場是基因治療開發的核心，主要促進遺傳物質向宿主細胞的傳遞。該服務定義了將 DNA 安全有效地包裝到 AAV 載體中，已知 AAV 載體是非致病性的，並表現出廣泛的組織向性。對 AAV 包裝服務的需求是由用於治療遺傳和罕見疾病的基因療法的擴展所推動的。應用涵蓋腫瘤學、神經病學和心臟病學等醫學領域，最終用途為製藥公司、研究機構和臨床實驗室。市場成長受到 CRISPR 技術進步、研發投資增加以及孤兒藥監管激勵等因素的影響。遺傳疾病的日益普及進一步推動了需求。然而，市場面臨生產高成本、監管環境嚴格以及影響供需不匹配的可擴展性問題等挑戰。機會存在於改進載體設計以實現高效基因轉移、探索合成生物學以獲得更好的有效負載能力以及增強可擴展的製造過程。建議投資生物資訊學和人工智慧以實現精確的載體客製化，以保持領先地位。新興國家對具有成本效益的基因治療解決方案的需求不斷成長。與學術界和生物技術公司的合作可以加速創新和市場滲透。然而，存在需要進一步調查和倫理考慮的局限性，例如知識產權的複雜性和脫靶效應的可能性。隨著研究和技術的不斷發展，AAV 包裝服務市場呈現出充足的創新空間，特別是在開發具有更高特異性和更低免疫抗原性的下一代載體方面。總體而言，策略重點是克服生產挑戰和有效應對法律規範可以實現顯著的業務成長，相關人員將從這個快速成長的細分市場中受益，並保持優勢地位。

主要市場統計
基準年[2023] 17.2億美元
預測年份 [2024] 18.4億美元
預測年份 [2030] 24.9億美元
複合年成長率（%） 5.39%

市場動態：揭示快速發展的 AAV 包裝服務市場的關鍵市場洞察

AAV 包裝服務市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助組織降低政治、地理、技術、社會和經濟領域的風險，以及消費行為及其對製造成本的影響，還可以更清楚地了解其對採購趨勢的影響。

波特五力：駕馭 AAV 包裝服務市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解 AAV 包裝服務市場的外部影響

外部宏觀環境因素在塑造 AAV 包裝服務市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解 AAV 包裝服務市場的競爭格局

對 AAV 包裝服務市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 AAV 包裝服務市場供應商的績效評估

FPNV 定位矩陣是評估 AAV 包裝服務市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了 AAV 包裝服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對 AAV 包裝服務市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告提供了涵蓋關鍵焦點細分市場的全面市場分析。

1. 市場滲透率：對當前市場環境的詳細回顧。

2. 市場開拓：辨識新興市場的成長機會，評估現有產業的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢視市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 基因治療研究的進展增加了對 AAV 包裝服務的需求
      • 越來越多的遺傳疾病需要有效的基因傳遞解決方案
      • 製藥公司加大基因治療的投資
      • 增加政府對基因研究和開發的支持和資助
    • 抑制因素
      • AAV 包裝服務缺乏標準化通訊協定限制了市場擴張
      • 智慧財產權問題和專利糾紛正在阻礙AAV包裝服務的進展
    • 機會
      • 為製藥公司提供可擴展的 AAV 包裝解決方案以進行藥物開發
      • 與學術機構合作進行 AAV 載體設計與應用的創新研究
      • 最佳化 AAV 包裝通訊協定以提高產量和品管標準
    • 任務
      • 解決 AAV 包裝服務產業的高成本和投資要求，實現可擴展生產
      • 滿足日益成長的個人化 AAV 包裝服務需求，以滿足特定治療需求
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 AAV 包裝服務市場：依應用分類

  • 介紹
  • 心臟病學
  • 細胞療法
    • CAR-T療法
    • 幹細胞療法
  • 基因治療
    • 單基因疾病
    • 多基因疾病
  • 神經病學
  • 腫瘤學
  • 眼科
  • 疫苗學
    • 癌症疫苗
    • 感染疾病

第 7 章 AAV 包裝服務市場：依最終用戶分類

  • 介紹
  • 學術機構
  • 生物製藥公司
  • 合約研究組織（CRO）
  • 研究所

第 8 章 AAV 包裝服務市場：按向量類型

  • 介紹
  • 腺結合病毒1 (AAV1)
  • 腺結合病毒2 (AAV2)
  • 腺結合病毒5 (AAV5)
  • 腺結合病毒6 (AAV6)
  • 腺結合病毒8 (AAV8)
  • 腺結合病毒9 (AAV9)

第9章 AAV 包裝服務市場：依製造方法分類

  • 介紹
  • 桿狀病毒/Sf9系統
  • 細胞株包裝
  • 瞬時轉染

第 10 章 AAV 包裝服務市場：按組成部分

  • 介紹
  • 反向末端重複序列 (ITR)
  • 發起人
  • 基因改造
  • 向量衣殼

第11章美洲AAV包裝服務市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區 AAV 包裝服務市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲AAV包裝服務市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-546E6FBB35F6

The AAV Packaging Service Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.84 billion in 2024, and is projected to grow at a CAGR of 5.39%, to USD 2.49 billion by 2030.

The AAV (Adeno-Associated Virus) Packaging Service market is at the heart of gene therapy development, primarily facilitating the delivery of genetic material into host cells. This service defines the safe and efficient packaging of DNA into AAV vectors, which are known for being non-pathogenic and exhibiting broad tissue tropism. The necessity for AAV packaging services is driven by the expanding gene therapy landscape, aimed at treating genetic and rare diseases. Applications extend across healthcare domains including oncology, neurology, and cardiology, with end-use spanning pharmaceutical companies, research institutions, and clinical labs. Market growth is influenced by factors such as advancements in CRISPR technology, increasing R&D investments, and regulatory incentives for orphan drugs. The growing prevalence of genetic disorders further fuels demand. However, the market faces challenges like high costs associated with production, stringent regulatory landscapes, and scalability issues impacting supply and demand mismatches. Opportunities lie in improving vector designs for efficient gene delivery, exploring synthetic biology for better payload capacity, and enhancing scalable manufacturing processes. Investing in bioinformatics and AI for precise vector customization is recommended to stay ahead. Regional market shifts present openings in emerging economies, where the demand for cost-effective gene therapy solutions is rising. Collaborations with academia and biotech firms can accelerate innovation and market penetration. Limitations still include IP complexities and potential off-target effects, necessitating further research and ethical considerations. As research and technological advances continue to evolve, the AAV Packaging Service market presents ample room for innovation, particularly in developing next-generation vectors with enhanced specificity and reduced immunogenicity. Overall, a strategic focus on overcoming production challenges and navigating regulatory frameworks efficiently can unlock substantial business growth, keeping stakeholders well-positioned in this burgeoning field.

KEY MARKET STATISTICS
Base Year [2023] USD 1.72 billion
Estimated Year [2024] USD 1.84 billion
Forecast Year [2030] USD 2.49 billion
CAGR (%) 5.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving AAV Packaging Service Market

The AAV Packaging Service Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Advancements in gene therapy research driving demand for AAV packaging services
    • Rising prevalence of genetic disorders necessitating efficient gene delivery solutions
    • Increasing investment from pharmaceutical companies in gene therapy initiatives
    • Growing governmental support and funding for genetic research and development
  • Market Restraints
    • Lack of standardized protocols in AAV packaging services limiting market expansion
    • Intellectual property issues and patent disputes hindering advancements in AAV packaging services
  • Market Opportunities
    • Targeting pharmaceutical companies with scalable AAV packaging solutions for drug development
    • Partnering with academic institutions for innovative research in AAV vector design and application
    • Optimizing AAV packaging protocols to improve production yield and quality control standards
  • Market Challenges
    • Addressing the high costs and investment requirements in the AAV packaging service industry for scalable production
    • Meeting the increasing demand for personalized AAV packaging services to cater to specific therapeutic needs

Porter's Five Forces: A Strategic Tool for Navigating the AAV Packaging Service Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the AAV Packaging Service Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the AAV Packaging Service Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the AAV Packaging Service Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the AAV Packaging Service Market

A detailed market share analysis in the AAV Packaging Service Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the AAV Packaging Service Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the AAV Packaging Service Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the AAV Packaging Service Market

A strategic analysis of the AAV Packaging Service Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the AAV Packaging Service Market, highlighting leading vendors and their innovative profiles. These include 4D Molecular Therapeutics, Adverum Biotechnologies, Asklepios BioPharmaceutical, Audentes Therapeutics, Baylor College of Medicine, Biogen, Brammer Bio, Dimension Therapeutics, Freeline Therapeutics, Genethon, Lonza, Oxford Biomedica, REGENXBIO, SIRION Biotech, Spark Therapeutics, Thermo Fisher Scientific, Vigene Biosciences, Virovek, Voyager Therapeutics, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the AAV Packaging Service Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Cardiology, Cell Therapy, Gene Therapy, Neurology, Oncology, Ophthalmology, and Vaccinology. The Cell Therapy is further studied across CAR-T Therapy and Stem Cell Therapy. The Gene Therapy is further studied across Monogenic Disorders and Multigenic Disorders. The Vaccinology is further studied across Cancer Vaccines and Infectious Diseases.
  • Based on End User, market is studied across Academic Institutions, Biopharmaceutical Companies, Contract Research Organizations (CROs), and Research Institutes.
  • Based on Vector Type, market is studied across Adeno-Associated Virus 1 (AAV1), Adeno-Associated Virus 2 (AAV2), Adeno-Associated Virus 5 (AAV5), Adeno-Associated Virus 6 (AAV6), Adeno-Associated Virus 8 (AAV8), and Adeno-Associated Virus 9 (AAV9).
  • Based on Production Method, market is studied across Baculovirus/Sf9 System, Packaging Cell Lines, and Transient Transfection.
  • Based on Component, market is studied across Inverted Terminal Repeats (ITRs), Promoters, Transgene, and Vector Capsid.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Advancements in gene therapy research driving demand for AAV packaging services
      • 5.1.1.2. Rising prevalence of genetic disorders necessitating efficient gene delivery solutions
      • 5.1.1.3. Increasing investment from pharmaceutical companies in gene therapy initiatives
      • 5.1.1.4. Growing governmental support and funding for genetic research and development
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standardized protocols in AAV packaging services limiting market expansion
      • 5.1.2.2. Intellectual property issues and patent disputes hindering advancements in AAV packaging services
    • 5.1.3. Opportunities
      • 5.1.3.1. Targeting pharmaceutical companies with scalable AAV packaging solutions for drug development
      • 5.1.3.2. Partnering with academic institutions for innovative research in AAV vector design and application
      • 5.1.3.3. Optimizing AAV packaging protocols to improve production yield and quality control standards
    • 5.1.4. Challenges
      • 5.1.4.1. Addressing the high costs and investment requirements in the AAV packaging service industry for scalable production
      • 5.1.4.2. Meeting the increasing demand for personalized AAV packaging services to cater to specific therapeutic needs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. AAV Packaging Service Market, by Application

  • 6.1. Introduction
  • 6.2. Cardiology
  • 6.3. Cell Therapy
    • 6.3.1. CAR-T Therapy
    • 6.3.2. Stem Cell Therapy
  • 6.4. Gene Therapy
    • 6.4.1. Monogenic Disorders
    • 6.4.2. Multigenic Disorders
  • 6.5. Neurology
  • 6.6. Oncology
  • 6.7. Ophthalmology
  • 6.8. Vaccinology
    • 6.8.1. Cancer Vaccines
    • 6.8.2. Infectious Diseases

7. AAV Packaging Service Market, by End User

  • 7.1. Introduction
  • 7.2. Academic Institutions
  • 7.3. Biopharmaceutical Companies
  • 7.4. Contract Research Organizations (CROs)
  • 7.5. Research Institutes

8. AAV Packaging Service Market, by Vector Type

  • 8.1. Introduction
  • 8.2. Adeno-Associated Virus 1 (AAV1)
  • 8.3. Adeno-Associated Virus 2 (AAV2)
  • 8.4. Adeno-Associated Virus 5 (AAV5)
  • 8.5. Adeno-Associated Virus 6 (AAV6)
  • 8.6. Adeno-Associated Virus 8 (AAV8)
  • 8.7. Adeno-Associated Virus 9 (AAV9)

9. AAV Packaging Service Market, by Production Method

  • 9.1. Introduction
  • 9.2. Baculovirus/Sf9 System
  • 9.3. Packaging Cell Lines
  • 9.4. Transient Transfection

10. AAV Packaging Service Market, by Component

  • 10.1. Introduction
  • 10.2. Inverted Terminal Repeats (ITRs)
  • 10.3. Promoters
  • 10.4. Transgene
  • 10.5. Vector Capsid

11. Americas AAV Packaging Service Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific AAV Packaging Service Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa AAV Packaging Service Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 4D Molecular Therapeutics
  • 2. Adverum Biotechnologies
  • 3. Asklepios BioPharmaceutical
  • 4. Audentes Therapeutics
  • 5. Baylor College of Medicine
  • 6. Biogen
  • 7. Brammer Bio
  • 8. Dimension Therapeutics
  • 9. Freeline Therapeutics
  • 10. Genethon
  • 11. Lonza
  • 12. Oxford Biomedica
  • 13. REGENXBIO
  • 14. SIRION Biotech
  • 15. Spark Therapeutics
  • 16. Thermo Fisher Scientific
  • 17. Vigene Biosciences
  • 18. Virovek
  • 19. Voyager Therapeutics
  • 20. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. AAV PACKAGING SERVICE MARKET RESEARCH PROCESS
  • FIGURE 2. AAV PACKAGING SERVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. AAV PACKAGING SERVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. AAV PACKAGING SERVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AAV PACKAGING SERVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AAV PACKAGING SERVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY MONOGENIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY MULTIGENIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 1 (AAV1), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 2 (AAV2), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 5 (AAV5), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 6 (AAV6), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 8 (AAV8), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS 9 (AAV9), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY BACULOVIRUS/SF9 SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PACKAGING CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY TRANSIENT TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY INVERTED TERMINAL REPEATS (ITRS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY PROMOTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY TRANSGENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR CAPSID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES AAV PACKAGING SERVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 288. NORWAY AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 296. POLAND AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 304. QATAR AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 312. RUSSIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 320. SAUDI ARABIA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 328. SOUTH AFRICA AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY VECTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 335. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 336. SPAIN AAV PACKAGING SERVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN AAV PACKAGING SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN AAV PACKAGING SERVICE MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN AAV PACKAGING SERVICE MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN AAV PACKAGING SERVICE MARKET SIZE, BY VACCINOLOGY, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN AAV PACKAGING SER